Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Director departure
Quarterly results
Appointed director
|
|
Cardiff Oncology, Inc. (TROV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Smeal Tod (Chief Scientific Officer) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 167,088 options
@ $1.72, valued at
$287.4k
|
|
| 03/16/2023 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 197,472 options
@ $1.72, valued at
$339.7k
|
|
| 03/16/2023 |
4
| Kelemen Vicki (Exec. VP and COO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 125,520 options
@ $1.72, valued at
$215.9k
|
|
| 03/16/2023 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 482,064 options
@ $1.72, valued at
$829.2k
|
|
| 02/09/2023 |
3
| Kabbinavar Fairooz (Chief Medical Officer) has filed a Form 3 on Cardiff Oncology, Inc. |
| 11/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 13,000 shares
@ $1.5564, valued at
$20.2k
|
|
| 09/20/2022 |
4
| White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 15,000 shares
@ $1.635, valued at
$24.5k
|
|
| 09/19/2022 |
4
| TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 6,400 shares
@ $1.715, valued at
$11k
Bought 3,600 shares
@ $1.72, valued at
$6.2k
|
|
| 09/19/2022 |
4
| PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 150,000 shares
@ $1.71, valued at
$256.5k
|
|
| 09/19/2022 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 30,000 shares
@ $1.557, valued at
$46.7k
|
|
| 07/06/2022 |
4
| White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Exercised 28,858 shares
@ $2.6, valued at
$75k
Exercised 28,858 options
@ $2.6, valued at
$75k
|
|
| 06/09/2022 |
4
| BRANCACCIO JOHN P (Former Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Acquired 26,800 options
@ $2.5, valued at
$67k
Acquired 22,000 options
@ $7.98, valued at
$175.6k
Acquired 28,858 options
@ $2.6, valued at
$75k
Acquired 44,734 options
@ $2.48, valued at
$110.9k
Acquired 755 options
@ $21.6, valued at
$16.3k
Acquired 530 options
@ $51.84, valued at
$27.5k
Acquired 223 options
@ $372.96, valued at
$83.2k
Acquired 223 options
@ $516.96, valued at
$115.3k
Acquired 195 options
@ $316.08, valued at
$61.6k
|
|
| 03/11/2022 |
4
| PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| Ruffner Katherine L (Chief Medical Officer) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 170,016 options
@ $2.5, valued at
$425k
|
|
| 03/10/2022 |
4
| Mohindru Mani (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| Markin Rodney S (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 170,016 options
@ $2.5, valued at
$425k
|
|
| 03/10/2022 |
4
| Kelemen Vicki (Exec. VP and COO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 170,016 options
@ $2.5, valued at
$425k
|
|
| 03/10/2022 |
4
| Erlander Mark (CEO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 370,128 options
@ $2.5, valued at
$925.3k
|
|
| 03/10/2022 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 03/10/2022 |
4
| Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 01/14/2022 |
3
| Smeal Tod (Chief Scientific Officer) has filed a Form 3 on Cardiff Oncology, Inc. |
| 09/22/2021 |
4
| PACE GARY W (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 30,000 shares
@ $6.75, valued at
$202.5k
|
|
| 09/13/2021 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 5,000 shares
@ $6.62, valued at
$33.1k
Bought 5,000 shares
@ $6.75, valued at
$33.8k
Bought 10,000 shares
@ $6.38, valued at
$63.8k
Bought 5,000 shares
@ $6.35, valued at
$31.8k
Bought 5,000 shares
@ $6.32, valued at
$31.6k
|
|
| 07/14/2021 |
4
| Ruffner Katherine L (Chief Medical Officer) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 200,000 options
@ $6.55, valued at
$1.3M
|
|
| 07/13/2021 |
3
| Ruffner Katherine L (Chief Medical Officer) has filed a Form 3 on Cardiff Oncology, Inc. |
| 07/12/2021 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 390,000 options to buy
@ $6.55, valued at
$2.6M
|
|
| 07/12/2021 |
3
| Levine James E. (CFO) has filed a Form 3 on Cardiff Oncology, Inc. |
| 06/15/2021 |
4
| JACOB GARY S (Former Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Acquired 28,858 options
@ $2.6, valued at
$75k
Acquired 293 options
@ $447.84, valued at
$131.2k
Acquired 218 options
@ $316.08, valued at
$68.9k
Acquired 223 options
@ $516.96, valued at
$115.3k
Acquired 223 options
@ $372.96, valued at
$83.2k
Acquired 530 options
@ $51.84, valued at
$27.5k
Acquired 755 options
@ $21.6, valued at
$16.3k
Acquired 44,734 options
@ $2.48, valued at
$110.9k
|
|
| 06/14/2021 |
4
| White Lale (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 22,000 options
@ $7.98, valued at
$175.6k
|
|
| 06/14/2021 |
4
| TANNENBAUM RENEE P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 44,001 options
@ $7.98, valued at
$351.1k
|
|
|
|
|